ArticleFrontiers in oncology2022

Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study.

Sander Ellegård et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.